Korea’s Daewoong Pharmaceutical Joins With Turkey’s Abdi Ibrahim On Renal, Foot Ulcer Treatments
This article was originally published in PharmAsia News
Executive Summary
South Korean drug companies are looking to make inroads into emerging markets through a combination of distribution deals, and Daewoong Pharmaceutical has made its move through a deal with Turkey’s leading drug company.